Cyberonics posts record sales in fiscal '13; Bacterin raising $4.9M;

@FierceMedDev: NeuroMetrix preferred stock placement pulls in $5M. Item | Follow @FierceMedDev

@DamianFierce: Amid efficacy worries from the FDA, Abbott posted more positive results for MitralClip. Report | Follow @DamianFierce

@MarkHFierce: Our latest special report - a closer look at six device and Dx startups making waves. Feature | Follow @MarkHFierce

> Cyberonics ($CYBX) posted record sales of $254 million last fiscal year, a 16% jump over 2012, and net income rose 28% to $46.4 million. Results

> Providence Medical Technology in San Francisco won the FDA's 510(k) clearance for its PMT cervical cage, a minimally invasive implant and drug delivery system for cervical fusion procedures. Item

> Bacterin ($BONE) is looking to raise about $4.9 million in a stock sale, money the company will use on operating expenses and working capital. News

> The Department of Health and Human Services has authorized the FDA to fast-track approval for diagnostics that detect Middle East respiratory syndrome coronavirus, which the feds have deemed a threat to public health and national security. Article

> Cohera Medical has completed enrollment in an FDA-targeted study of TissuGlu, an internal adhesive designed to stick to tissue flaps during surgery. The company raised $17 million in venture cash in February to fund the device's development. More

> Echo Therapeutics ($ECTE) has launched a CE mark trial for Symphony CGM, a non-invasive continuous glucose monitor. Release

> Vycor Medical says it has obtained yet another patent for its 510(k) cleared NovaVision device designed to help restore neurologically induced vision loss. Item

Biotech News

@FierceBiotech: ICYMI: NIH lays out effects of sequestration on biomedical research. Article | Follow @FierceBiotech

@JohnCFierce: Aveo slashes 140 jobs, halts R&D work related to doomed FDA drug application. News | Follow @JohnCFierce

@RyanMFierce: GenoSpace joins growing alliance for sharing translational research data. Article | Follow @RyanMFierce

@EmilyMFierce: More New Yorkers skipping vaccines on religious grounds. Story | Follow @EmilyMFierce

> Can India's Biocon land a global partner for its new psoriasis drug? More

> Johnson & Johnson takes rare gamble on microbiome science of biotech startup. News

> J&J pitches plan to spawn new biotechs, strike deals in San Francisco. Article

Pharma News

@FiercePharma: Swedish drugmaker Meda says it's not in buyout talks. Sun Pharma had reportedly been eyeing a deal. More | Follow @FiercePharma

@EricPFierce: FDA tells Novartis in warning letter it doesn't like what it sees at Austria plant, particles in vials. More | Follow @EricPFierce

@CarlyHFierce: India's officials have been tough on Big Pharma but may now resurrect Pfizer's Sutent patent. Article | Follow @CarlyHFierce

> Sky-high drug prices will force change in cancer care, experts say. Story

> Novartis' Sandoz unit stumbles again. Report

> Meda responds to Sun buyout reports with firm 'no deal.' Article

Drug Delivery News

@MichaelGFierce: Novel oral drugs spur big investments for Akebia, Protagonist. Article | Follow @MichaelGFierce

> Hydrogels deliver immuno drugs to transplanted hands. Story

> Janssen Labs-based Arcturus gets $1.3M boost for RNAi delivery tech. Item

> In study, nasal spray cuts addictive binge eating in obese patients. More

> Nanoparticles release chemo when activated with red light. Story

Sponsored By Metabolon

Five Translational Insights Key to a Successful First-in-Human (FIH) Study – Metabolite-Based Biomarker Discovery and Validation

Translational success rates from pre-clinical animal studies to human clinical trials remain frustratingly low. Learn how metabolomics helps you bridge between the theoretical & practical, between the function & actual activity of your drug molecule to get you closer to the phenotype, sooner.